Md Samiul Islam | Pharmacology, Toxicology and Pharmaceutical Science | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Md Samiul Islam
Kyushu University, Japan

Md Samiul Islam
Affiliation Kyushu University
Country Japan
Scopus ID 57713850900
Documents 8
Citations 70
h-index 6
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event Global Innovation Technologist Awards

The Innovative Research Award recognition highlights the scholarly contributions of Md Samiul Islam, a researcher affiliated with Kyushu University, Japan. His research activities are associated with the fields of pharmacology, toxicology, pharmaceutical sciences, biotechnology, and molecular engineering. Through peer-reviewed publications and interdisciplinary scientific investigations, he has contributed to advancing knowledge in biomolecular interactions and peptide engineering. His publication record, citation performance, and emerging research influence demonstrate active participation in contemporary scientific research and innovation.[1]

Abstract

Md Samiul Islam has contributed to research involving biomolecular recognition, peptide development, and pharmaceutical sciences. His scientific output includes studies focused on protein-binding mechanisms and recombinant protein technologies. The research portfolio reflects an interdisciplinary approach combining biotechnology, molecular biology, and applied pharmaceutical sciences. These contributions support ongoing advancements in targeted therapeutic development and molecular engineering methodologies.[2]

Keywords

Peptide Engineering, Recombinant Proteins, Molecular Recognition, Pharmacology, Biotechnology, Drug Discovery, Pharmaceutical Science, Protein Binding.

Introduction

Modern pharmaceutical and biomedical research increasingly depends on understanding molecular interactions and designing biologically active compounds. Researchers working in these areas contribute to the development of innovative diagnostic and therapeutic strategies. Md Samiul Islam’s work aligns with these objectives through investigations involving peptide selection technologies and biomolecular targeting systems.[3]

Research Profile

According to indexed academic records, Md Samiul Islam has authored multiple scholarly publications and achieved measurable citation impact. His research activities are associated with Kyushu University and focus on pharmaceutical science, biotechnology, and molecular engineering. His publication metrics include 8 indexed documents, 70 citations, and an h-index of 6, reflecting recognized engagement within the scientific community.[1]

Research Contributions

  • Research on peptide discovery and molecular binding technologies.
  • Contributions to recombinant protein-based screening approaches.
  • Interdisciplinary studies connecting biotechnology and pharmaceutical sciences.
  • Support for emerging therapeutic and diagnostic innovation.

Publications

A notable publication is Directed evolution of Clec12a-binding peptides using mammalian-expressed recombinant protein, published in Biochemistry and Biophysics Reports (2026). The study explores peptide evolution and molecular binding strategies relevant to biomedical applications and protein-targeting research.[4]

Research Impact

The citation profile and publication record indicate that the research outputs have received scholarly attention. Work involving molecular recognition and peptide engineering contributes to broader scientific discussions related to biotechnology and pharmaceutical innovation. Such contributions support evidence-based advancement within the biomedical sciences.[5]

Award Suitability

The Innovative Research Award recognizes researchers demonstrating meaningful scientific contributions and emerging research impact. Based on documented publication activity, citation performance, and contributions to pharmaceutical and biotechnology research, Md Samiul Islam represents a suitable candidate for recognition within the Global Innovation Technologist Awards framework.[6]

Conclusion

Md Samiul Islam’s research activities demonstrate engagement in contemporary pharmaceutical and biotechnology investigations. Through publications, citation impact, and interdisciplinary scientific work, he contributes to the advancement of molecular engineering and biomedical research. His scholarly profile reflects ongoing participation in scientific innovation and knowledge development within his field.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Md Samiul Islam, Author ID 57713850900. Scopus.
    https://www.scopus.com/pages/authors/57713850900
  2. Kyushu University. (n.d.). Research activities and scientific publications.
  3. Biotechnology and pharmaceutical science literature concerning molecular recognition systems.
  4. Kawaguchi, Y., Islam, M.S., Yokoyama, M., Kamiya, N., & Goto, M. (2026). Directed evolution of Clec12a-binding peptides using mammalian-expressed recombinant protein. Biochemistry and Biophysics Reports.
    https://doi.org/10.1016/j.bbrep.2026.101900
  5. Elsevier. (n.d.). Scopus citation metrics and scholarly impact indicators.
  6. Global Innovation Technologist Awards. (n.d.). Award evaluation and recognition framework.
    innovationtechnologist.com

Trideep Saikia | Pharmaceutics | Best Researcher Award

Published on by Innovation Technologist

Mr. Trideep Saikia | Pharmaceutics | Best Researcher Award

Assistant Professor at Girijananda Chowdhury University, India

Mr. Trideep Saikia is a dynamic pharmaceutical researcher and academic with a strong foundation in scientific writing, advanced drug delivery systems, and preclinical pharmacological studies. His work spans diabetes and cancer research, with significant contributions in nanoformulation, dry powder inhalers, and targeted therapy using animal models. Currently serving as an Assistant Professor at Girijananda Chowdhury University, he combines academic leadership with cutting-edge research and scientific publication. Mr. Saikia is also an active peer reviewer and patent contributor, with a growing global impact in pharmaceutical sciences.

Publication ProfileΒ 

Scopus

Google Scholar

Educational Background πŸŽ“

  • Ph.D. in Pharmaceutical Sciences (Ongoing) – Dibrugarh University

  • MBA in Marketing Management (Ongoing) – Mizoram University

  • M.Pharm in Pharmaceutics – Mizoram University, 2020 (86.2%)

  • B.Pharm – Assam Science and Technology University, 2017 (78.6%)

  • PG Diploma in Computer Applications – IITA, Guwahati, 2013 (Grade A)

Professional Experience πŸ’Ό

1. Assistant Professor
Girijananda Chowdhury University, Guwahati
Jan 2021 – Present

  • Led lectures in pharmaceutics and mentored student researchers

  • Authored 18+ peer-reviewed publications

  • Operated key analytical instruments (HPLC, SEM, DSC)

2. Junior Research Fellow
Assam Down Town University & NIPER-Guwahati
Aug 2020 – Jan 2021

  • Preclinical studies on diabetes using rat models

  • Manuscript writing and data visualization

3. Research Trainee
CSIR-NEIST
Jul 2019 – Jun 2020

  • In vitro cancer research, analytical techniques, and cell culture studies

4. Medical Representative
Novartis India Ltd.
Aug 2017 – Aug 2018

  • Promoted pharmaceutical products and conducted market analysis

Research Interests πŸ”¬

  • Preclinical Drug Evaluation (Diabetes, Cancer)

  • Advanced Drug Delivery Systems: Nanoformulations, Dry Powder Inhalers

  • In vitro and In vivo Pharmacological Testing

  • Pharmacokinetics and Pharmacodynamics

  • Scientific Communication and Research Writing

Awards and HonorsπŸ†βœ¨

  • Peer Reviewer for high-impact journals under Dove Medical Press, including:

    • International Journal of Nanomedicine (IF 7.5)

    • Journal of Inflammation Research (IF 4.6)

    • Cancer Management and Research (IF 2.5)

  • Granted German Patent: Novel multiepitope vaccine design

  • Indian Patent Published: Surgical Stiletto for maxillary dissection in Danio rerio

  • Poster Presentations:

    • ESTEC-2020 (CSIR-NEIST, Jorhat)

    • 68th Indian Pharmaceutical Congress, Visakhapatnam

    • North East Pharmaceutical Convention-2017, Guwahati

Conclusion🌟

Mr. Trideep Saikia exemplifies a strong blend of academic excellence, innovative pharmaceutical research, and scientific communication expertise. With substantial experience in drug delivery systems, a growing list of publications, and a commendable involvement in peer review and patent innovation, he stands out as a promising contributor to pharmaceutical and biomedical research. Continued focus on clinical translation and international collaboration will further enhance his impact.

Publications πŸ“š

πŸ“„ Development of Dry Powder Inhaler formulation for site specific delivery of nanoconjugates loaded with Curcumin and BCL2 siRNA in Lung Cancer
πŸ‘₯ M. Lahan, T. Saikia, R. Baishya, A. Bharali, S. Baruah, S. Ghosh, N. Biswas, …
πŸ“š Pulmonary Pharmacology & Therapeutics | πŸ—“οΈ 2025 | πŸ†” 102361 | πŸ“ˆ In press

πŸ“„ QBD based and Box-Behnken Design based PLGA Nanoparticles for Sustained Release of Curcumin (Cur-PLGA-NS) In A549 Lung Cancer Cells
πŸ‘₯ M. Lahan, S.K. Sarma, T. Saikia, K. Dutta, R. Baishya, A. Bharali, J. Nath, …
πŸ“š Journal of Chemical Health Risks | πŸ—“οΈ 2025 | πŸ“‘ 15(3), 1140–1450 | πŸ“ˆ In press

πŸ“„ Lipid-drug conjugates for cancer chemotherapy
πŸ‘₯ T. Saikia, B.P. Sahu, M.K. Das
πŸ“š Lipid-Drug Conjugates | πŸ—“οΈ 2025 | πŸ“‘ 191–219 | πŸ“ˆ In press

πŸ“„ Multifunctional approach with LHRH-mediated PLGA nanoconjugate for site-specific codelivery of curcumin and BCL2 siRNA in mice lung cancer
πŸ‘₯ M. Lahan, T. Saikia, K. Dutta, R. Baishya, A. Bharali, S. Baruah, R. Bharadwaj, …
πŸ“š Future Journal of Pharmaceutical Sciences | πŸ—“οΈ 2024 | πŸ“‘ 10(1), 163 | πŸ“ˆ 2 citations

πŸ“„ Citrus aurantifolia-derived carbon quantum dots with red fluorescence emission for codelivery with curcumin as theranostic liposomes for lung cancer
πŸ‘₯ A. Sonowal, A. Bharali, T. Saikia, S. Kushari, M. Lahon, J.M. Kalita, N. Biswas, …
πŸ“š Future Journal of Pharmaceutical Sciences | πŸ—“οΈ 2024 | πŸ“‘ 10(1), 116 | πŸ“ˆ 1 citation

πŸ“„ Enhanced Lung Cancer Therapy via Co-Encapsulation of Docetaxel and Betulinic Acid
πŸ‘₯ T. Saikia, P. Rajak, B.P. Sahu, L. Patowary
πŸ“š Drugs and Drug Candidates | πŸ—“οΈ 2024 | πŸ“‘ 3(3), 566–597 | πŸ“ˆ 2 citations

πŸ“„ Development of paclitaxel proliposomal dry powder inhaler (PTX-PLM-DPI) by freeze-drying method for lung cancer
πŸ‘₯ C. Borah, T. Saikia, A. Bharali, M. Lahan, N. Biswas, B.P. Sahu
πŸ“š Drugs and Drug Candidates | πŸ—“οΈ 2024 | πŸ“‘ 3(1), 275–290 | πŸ“ˆ 3 citations

πŸ“„ Mechanistic Aspects of Neurodegeneration in Alzheimer’s Disease and the Role of Phytochemicals
πŸ‘₯ T. Saikia, T. Kalita, B.P. Sahu, P. Rajak, B. Deka, A. Bharali
πŸ“š Computational and Experimental Studies in Alzheimer’s Disease | πŸ—“οΈ 2024 | πŸ“‘ 91–121 | πŸ“ˆ In press

πŸ“„ 3-D models for studying microplastics effects on humans
πŸ‘₯ Y. Aryanfar, Y.S. Wu, J.L.G. Alcaraz, R.P.I. Vidal, A.I. Osman, A.S.A. Manap, T. Saikia, …
πŸ“š Microplastics in Agriculture and Food Science | πŸ—“οΈ 2025 | πŸ“‘ 417–441 | πŸ“ˆ In press

πŸ“„ Bioconversion of organic waste by insects – A comprehensive review
πŸ‘₯ S.A. Siddiqui, I.A. Harahap, J. Osei-Owusu, T. Saikia, Y.S. Wu, I. Fernando, …
πŸ“š Process Safety and Environmental Protection | πŸ—“οΈ 2024 | πŸ“ˆ 25 citations

πŸ“„ Production and growth of microalgae in urine and wastewater: A review
πŸ‘₯ S.A. Siddiqui, Y.S. Wu, T. Saikia, Δ°. Ucak, M. Afreen, M.A. Shah, R.D. Ayivi
πŸ“š Environmental Chemistry Letters | πŸ—“οΈ 2023 | πŸ“‘ 21(5), 2789–2823 | πŸ“ˆ 2 citations

πŸ“„ Microplastic sources, formation, toxicity and remediation: a review
πŸ‘₯ A.I. Osman, M. Hosny, A.S. Eltaweil, S. Omar, A.M. Elgarahy, M. Farghali, T. Saikia, …
πŸ“š Environmental Chemistry Letters | πŸ—“οΈ 2023 | πŸ“‘ 21(4), 2129–2169 | πŸ“ˆ 469 citations